Stanford Health Care - Skin Cancer Program

Stanford, California 94304

1 studies enrolling now · 1 studies all time

What they study most

Advanced Or Metastatic Merkel Cell Carcinoma

Studies at this site

• Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma — Recruiting now